Phibro Animal Health (NASDAQ:PAHC) Raised to “Neutral” at BNP Paribas Exane

Phibro Animal Health (NASDAQ:PAHC) was upgraded by equities research analysts at BNP Paribas Exane from an “underperform” rating to a “neutral” rating in a research note issued to investors on Monday, Marketbeat reports. The firm presently has a $24.00 price target on the stock. BNP Paribas Exane’s price target would indicate a potential downside of 1.84% from the company’s current price.

Several other research analysts have also recently issued reports on the stock. Morgan Stanley lifted their target price on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an “equal weight” rating in a report on Thursday, May 8th. Wall Street Zen raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Friday, May 9th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, Phibro Animal Health presently has a consensus rating of “Hold” and a consensus target price of $20.80.

Phibro Animal Health Price Performance

Shares of PAHC opened at $24.45 on Monday. The stock has a market cap of $990.96 million, a PE ratio of 31.35, a price-to-earnings-growth ratio of 0.47 and a beta of 0.74. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.23 and a current ratio of 2.91. Phibro Animal Health has a fifty-two week low of $16.16 and a fifty-two week high of $26.55. The firm’s 50-day simple moving average is $21.39 and its two-hundred day simple moving average is $21.89.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.11. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%. The firm had revenue of $347.80 million for the quarter, compared to analysts’ expectations of $352.41 million. Analysts anticipate that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Sterling Capital Management LLC boosted its holdings in Phibro Animal Health by 2.4% in the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock worth $394,000 after purchasing an additional 448 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after buying an additional 484 shares during the period. Los Angeles Capital Management LLC lifted its holdings in shares of Phibro Animal Health by 2.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock valued at $505,000 after buying an additional 503 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Phibro Animal Health by 4.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company’s stock worth $260,000 after buying an additional 546 shares during the last quarter. Finally, New York State Teachers Retirement System grew its holdings in shares of Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after acquiring an additional 775 shares during the period. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.